SKYE BIOSCIENCE INC | SC 13G: Statement of acquisition of beneficial ownership by individuals-Janus Henderson Group plc(5.7%),Janus Henderson Biotech Innovation Master Fund Ltd(5.2%)
SKYE BIOSCIENCE INC | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
SKYE BIOSCIENCE INC | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
SKYE BIOSCIENCE INC | 10-Q: Q2 2024 Earnings Report
SKYE BIOSCIENCE INC | 4: Statement of changes in beneficial ownership of securities-Director Smith Karen L.
SKYE BIOSCIENCE INC | 3: Initial statement of beneficial ownership of securities-Director Smith Karen L.
SKYE BIOSCIENCE INC | 8-K: Current report
SKYE BIOSCIENCE INC | 8-K: Current report
SKYE BIOSCIENCE INC | EFFECT: Others
SKYE BIOSCIENCE INC | EFFECT: Others
SKYE BIOSCIENCE INC | 424B3: Prospectus
SKYE BIOSCIENCE INC | CORRESP: CORRESP
SKYE BIOSCIENCE INC | CORRESP: CORRESP
SKYE BIOSCIENCE INC | CORRESP: CORRESP
SKYE BIOSCIENCE INC | CORRESP: CORRESP
SKYE BIOSCIENCE INC | UPLOAD: Others
SKYE BIOSCIENCE INC | UPLOAD: Others
SKYE BIOSCIENCE INC | S-3: Registration statement for specified transactions by certain issuers
SKYE BIOSCIENCE INC | S-3: Registration statement for specified transactions by certain issuers
SKYE BIOSCIENCE INC | 10-Q: Q1 2024 Earnings Report
No Data